Gilead Sciences, Inc.

VANGUARD GROUP INC GILD

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

121,097,336

Value ($000)

14,863,487

Weight

0.2%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	14,863,487	0.2%	121,097,336	12/31/2025
2025 Q3	11/7/2025	13,207,184	0.2%	118,983,644	9/30/2025
2025 Q2	8/11/2025	13,233,912	0.2%	119,364,226	6/30/2025
2025 Q1	5/9/2025	13,162,606	0.2%	117,470,825	3/31/2025
2024 Q4	2/11/2025	10,671,358	0.2%	115,528,392	12/31/2024
2024 Q3	11/13/2024	9,670,347	0.2%	115,342,884	9/30/2024
2024 Q2	8/13/2024	7,908,110	0.2%	115,261,774	6/30/2024
2024 Q1	5/10/2024	8,404,161	0.2%	114,732,575	3/31/2024
2023 Q4	3/11/2024	9,058,735	0.2%	111,822,428	12/31/2023
2023 Q3	12/18/2023	8,369,642	0.2%	111,684,574	9/30/2023
2023 Q2	8/14/2023	8,737,322	0.2%	113,368,650	6/30/2023
2023 Q1	7/14/2023	9,373,486	0.2%	112,974,397	3/31/2023
2022 Q4	2/10/2023	9,618,490	0.3%	112,038,324	12/31/2022
2022 Q3	11/14/2022	6,914,663	0.2%	112,087,271	9/30/2022
2022 Q2	8/12/2022	6,823,581	0.2%	110,396,077	6/30/2022
2022 Q1	5/13/2022	6,278,417	0.1%	105,608,358	3/31/2022
2021 Q4	2/14/2022	7,682,413	0.2%	105,803,799	12/31/2021
2021 Q3	11/12/2021	7,348,594	0.2%	105,205,361	9/30/2021
2021 Q2	8/13/2021	7,231,535	0.2%	105,017,942	6/30/2021
2021 Q1	5/14/2021	6,738,565	0.2%	104,263,729	3/31/2021
2020 Q4	2/12/2021	5,988,372	0.2%	102,787,017	12/31/2020
2020 Q3	11/16/2020	6,491,033	0.2%	102,722,460	9/30/2020
2020 Q2	8/14/2020	8,064,339	0.3%	104,813,339	6/30/2020
2020 Q1	5/15/2020	8,006,304	0.3%	107,093,415	3/31/2020
2019 Q4	2/14/2020	6,743,094	0.2%	103,771,848	12/31/2019
2014 Q2	8/11/2014	6,528,422	0.5%	78,741,071	6/30/2014
2014 Q1	5/13/2014	5,476,645	0.5%	77,288,234	3/31/2014
2013 Q4	2/12/2014	5,624,796	0.5%	74,847,829	12/31/2013